Oncoc4 Inc.
Rockville, MD
- UEI
- JAAPHKL5VEJ8
- CAGE
- 8TLT1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 9640 Medical Center Dr, Rockville, MD 20850, USA
- Website
- oncoc4.com
- Founded
- 2020
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| First in human phase i/II clinical trial of ONC-392: preserving ctla-4 immune tolerance checkpoint for safer and more… | National Cancer Institute (NIH) | $5,214,353 |
Quick answers
Is Oncoc4 Inc. registered in SAM.gov?
Yes. Oncoc4 Inc.'s SAM.gov registration is active through September 27, 2027.
What is Oncoc4 Inc.'s most recent federal award?
Oncoc4 Inc.'s most recent federal grant award is First in human phase i/II clinical trial of ONC-392: preserving ctla-4 immune tolerance checkpoint for safer and more… (R44CA250824), from National Cancer Institute (NIH), on April 3, 2020.
On GovTribe
See Oncoc4 Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors